News & Events about Idexx Laboratories Inc.
Thinking about trading options or stock in Catalent, Tesla, IDEXX Laboratories, Exxon Mobil, or Regeneron Pharmaceuticals? Thinking about trading options or stock in Catalent, Tesla, IDEXX Laboratories, Exxon Mobil, or Regeneron Pharmaceuticals? PR Newswire NEW YORK, Feb. 6, 2023 NEW YORK, Feb. 6...
IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results PR Newswire WESTBROOK, Maine, Feb. 6, 2023 Achieves fourth quarter revenue growth of 3% reported and 7% organic, driven by CAG Diagnostics recurring revenue...
Treasurer of the State of North Carolina raised its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX Get Rating) by 0.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 36,873 shares of the companys stock after purchasing an additional 240 shares ...
IDEXX Laboratories, Inc. (NASDAQ:IDXX Get Rating) has received a consensus rating of Moderate Buy from the eleven ratings firms that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and seven have given a buy ...
IDEXX Laboratories, Inc. (NASDAQ:IDXX Get Rating) has been assigned a consensus rating of Moderate Buy from the eleven analysts that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and seven have given a buy ...